Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

OBJECTIVES: To develop evidence-based points to consider for cost-effective use of biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in the treatment of inflammatory rheumatic diseases, specifically rheumatoid arthritis, psoriatic arthritis and axial spondyloarthri...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Togt, Céleste J T, Van den Bemt, Bart, Aletaha, Daniel, Alten, Rieke, Chatzidionysiou, Katerina, Galloway, James, Isaac, John, Mulleman, Denis, Verschueren, P, Vulto, Arnold G, Welsing, Paco M J, Verhoef, Lise, den Broeder, Alfons A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990692/
https://www.ncbi.nlm.nih.gov/pubmed/36863753
http://dx.doi.org/10.1136/rmdopen-2022-002898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990692/
https://www.ncbi.nlm.nih.gov/pubmed/36863753
http://dx.doi.org/10.1136/rmdopen-2022-002898

Ejemplares similares